Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 ,inter alia, to consider and approve In terms of Regulation ....
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supriya Lifescience has informed BSE and NSE that its Board of Directors will meet on Tuesday, May 27, 2025. The main items on the agenda are to consider and approve the audited financial results for the quarter and full year ended March 31, 2025. The Board will also consider recommending a dividend, if any, on the company's equity shares for FY25. The trading window for designated persons and their immediate relatives has been closed since April 1, 2025 and will reopen 48 hours after the results are declared.
Investors should watch May 27 for the company's full-year FY25 earnings and any dividend announcement, which could be key near-term catalysts for the stock.